Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo.

By J. Goldstein, G. Eisen, B. Lewis, I. Gralnek, S. Zlotnick, J. Fort. Clinical Gastroenterology and Hepatology, 2005

627 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Oncology, Pharmacology

View Paper: https://www.semanticscholar.org/paper/8d2182e2da3b8983814dce8edb7825ede8762c42

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. Suryakanth R. Gurudu

Citations in the corpus

• Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline (2015, background): “Although recommendations in the current literature are heterogeneous, arbitrarily stopping these agents for at least 1 month before VCE appears to be an acceptable prudent strategy [123].”
• A Meta-Analysis of the Yield of Capsule Endoscopy Compared to Other Diagnostic Modalities in Patients with Non-Stricturing Small Bowel Crohn's Disease (2006, background): “In addition, two recent trials have reported an incidence of mucosal breaks seen on CE in healthy controls of 10–21% (16, 17).”